XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) – A High-Growth Stock Meeting Minervini’s Trend Template

XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) has been identified as a high-growth momentum stock that aligns with Mark Minervini’s Trend Template criteria. The company, specializing in biopharmaceutical therapies, demonstrates strong technical and fundamental characteristics that make it a candidate for further analysis.

Technical Strength: Meeting Minervini’s Trend Template

XERS satisfies key technical criteria from Minervini’s strategy, which focuses on stocks in strong uptrends:

• Price Above Key Moving Averages: The stock trades above its 50-day ($4.66), 150-day ($3.79), and 200-day ($3.51) moving averages, confirming a bullish trend.
• Rising Moving Averages: The 50-day MA is above both the 150-day and 200-day MAs, while the 150-day MA is above the 200-day MA—a sign of sustained upward momentum.
• Strong Relative Strength: With a ChartMill Relative Strength (CRS) score of 98.37, XERS outperforms nearly all stocks in its sector.
• Price Near 52-Week High: At $4.95, XERS is within 25% of its 52-week high ($6.07) and well above its 52-week low ($1.86).

Fundamental Growth Drivers

XERS exhibits accelerating growth, making it appealing for high-growth investors:

• Revenue Growth: Quarterly revenue growth stands at 47.94%, with year-over-year (TTM) growth at 23.89%.
• Earnings Momentum: EPS growth for the latest quarter surged 57.14%, with next-year EPS estimates revised upward by 63.85% over the past three months.
• Positive Earnings Surprises: The company has beaten revenue estimates in three of the last four quarters.

Industry and Market Position

XERS operates in the competitive pharmaceuticals sector, where it outperforms 96% of peers. Its commercial products—Recorlev, Gvoke, and Keveyis—along with a promising pipeline (including XP-8121 for hypothyroidism) suggest continued growth potential.

Technical Report Summary

The ChartMill Technical Report assigns XERS a perfect technical rating of 10, citing consistent performance across short and long-term trends. Key support levels are found between $4.39 and $4.50, while resistance lies near $5.02.

Our High Growth Momentum + Trend Template screener lists more stocks with similar high-growth and technical strength.

Disclaimer

This is not investment advice. Always conduct your own research before making financial decisions.